Changes in plasma concentration of taurine in stroke

Neuroscience Letters

Volumn 496, Issue 3, 2011, Pages 172-175

  Ghandforoush Sattari, Mohammadreza ^a,b   Mashayekhi, Simin O ^c   Nemati, Mahboob ^a   Ayromlou, Hormoz ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amino acid; Biomarker; HPLC; Stroke; Taurine

Indexed keywords

BIOLOGICAL MARKER; TAURINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE; STUDENT T TEST; TISSUE INJURY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; POTASSIUM; RECOVERY OF FUNCTION; SODIUM; STROKE; TAURINE; TIME FACTORS;

EID: 79955758954     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.010     Document Type: Article

References (48)

1. Bhatnagar S.K., Welty J.D., al Yusuf A.R. Significance of blood taurine levels in patients with first time acute ischaemic cardiac pain. Int. J. Cardiol. 1990, 27:361-366.
2. Butterworth R.F. Taurine in hepatic encephalopathy. Adv. Exp. Med. Biol. 1996, 403:601-606.
3. Carvalho F., Waterfield C., Ferreira M., Bastos M.d.L., Timbrell J. Effect of repeated exposure to salbutamol on urinary and liver taurine levels in rats. Hum. Exp. Toxicol. 1994, 13:291.
4. Castillo J., Martinez F., Corredera E., Aldrey J.M., Noya M. Amino acid transmitters in patients with headache during the acute phase of cerebrovascular ischemic disease. Stroke 1995, 26:2035-2039.
5. Collins B.W., Goodman H.O., Swanton C.H., Remy C.N. Plasma and urinary taurine in epilepsy. Clin. Chem. 1988, 34:671-675.
6. Desai T.K., Maliakkal J., Kinzie J.L., Ehrinpreis M.N., Luk G.D., Cejka J. Taurine deficiency after intensive chemotherapy and/or radiation. Am. J. Clin. Nutr. 1992, 55:708-711.
7. Durelli L., Quattrocolo G., Buffa C., Valentini C., Mutani R. Antagonism between focal epilepsy and taurine administered by cortical perfusion. Riv. Neurol. 1976, 46:254-261.
8. El Idrissi A., Messing J., Scalia J., Trenkner E. Prevention of epileptic seizures by taurine. Adv. Exp. Med. Biol. 2003, 526:515-525.
9. Friedman A.L., Albright P.W., Gusowski N., Padilla M., Chesney R.W. Renal adaptation to alteration in dietary amino acid intake. Am. J. Physiol. 1983, 245:F159-166.
10. Ghandforoush-Sattari M., Mashayekhi S. Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning. Eur. J. Pharmacol. 2008, 581:171-176.
11. Ghandforoush-Sattari M., Mashayekhi S., Nemati M., Routledge P.A. A rapid determination of taurine in human plasma by LC. Chromatographia 2009, 69:1427-1430.
12. M. Ghandforoush-Sattari, S. Mashayekhi, M. Nemati, A. Seydi, H. Azadi, Changes in plasma taurine concentration during a period of heroin detoxification, Toxicol. Environ. Chem. 92 (2010) 1505-1512.
13. Goodman H.O., Connolly B.M., McLean W., Resnick M. Taurine transport in epilepsy. Clin. Chem. 1980, 26:414-419.
14. Guerra-Romero L., Tureen J.H., Fournier M.A., Makrides V., Tauber M.G. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr. Res. 1993, 33:510-513.
15. Gupta R.C., Win T., Bittner S. Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr. Med. Chem. 2005, 12:2021-2039.
16. Haas H.L., Hosli L. The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. Brain Res. 1973, 52:399-402.
17. Harry F., Hale A., Buss D., Hutchings A., Routledge P. Serum taurine levels in healthy subjects and in paracetamol poisoned patients. Hum. Exp. Toxicol. 1999, 18:531.
18. Haskew-Layton R.E., Rudkouskaya A., Jin Y., Feustel P.J., Kimelberg H.K., Mongin A.A. Two distinct modes of hypoosmotic medium-induced release of excitatory amino acids and taurine in the rat brain in vivo. PLoS One 2008, 3:e3543.
19. Hegstad E., Berg-Johnsen J., Haugstad T.S., Hauglie-Hanssen E., Langmoen I.A. Amino-acid release from human cerebral cortex during simulated ischaemia in vitro. Acta Neurochir. (Wien) 1996, 138:234-241.
20. Hussy N., Deleuze C., Pantaloni A., Desarmenien M.G., Moos F. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J. Physiol. 1997, 502(Pt 3):609-621.
21. Huxtable R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 1989, 32:471-533.
22. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
23. Jiang Z., Krnjevic K., Wang F., Ye J.H. Taurine activates strychnine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. J. Neurophysiol. 2004, 91:248-257.
24. Kimelberg H.K. Current concepts of brain edema. Review of laboratory investigations. J. Neurosurg. 1995, 83:1051-1059.
25. Kirk K., Kirk J. Volume-regulatory taurine release from a human lung cancer cell line. Evidence for amino acid transport via a volume-activated chloride channel. FEBS Lett. 1993, 336:153-158.
26. Law R.O. The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochem. Int. 1998, 33:467-472.
27. Lee P., Brenton D. Inborn errors of amino acid and organic acid metabolism. Oxford Textbook of Medicine 2003, 9. Oxford University Press. D. Warrell, T. Cox, J. Firth (Eds.).
28. Melani A., Pantoni L., Corsi C., Bianchi L., Monopoli A., Bertorelli R., Pepeu G., Pedata F. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke 1999, 30:2448-2454. (discussion 2455).
29. Monaco F., Mutani R., Durelli L., Delsedime M. Free amino acids in serum of patients with epilepsy: significant increase in taurine. Epilepsia 1975, 16:245-249.
30. Mongin A., Kimelberg H. Astrocytic swelling in neuropathology. Neuroglia 2005, 550-562. Oxford University Press, Oxford-New York. H. Kettenmann, B. Ransom (Eds.).
31. Oja S.S., Saransaari P. Kinetic analysis of taurine influx into cerebral cortical slices from adult and developing mice in different incubation conditions. Neurochem. Res. 1996, 21:161-166.
32. Oja S.S., Saransaari P. Taurine as osmoregulator and neuromodulator in the brain. Metab. Brain Dis. 1996, 11:153-164.
33. Pasantes-Morales H., Arzate M.E. Effect of taurine on seizures induced by 4-aminopyridine. J. Neurosci. Res. 1981, 6:465-474.
34. Pasantes-Morales H., Arzate M.E., Quesada O., Huxtable R.J. Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine. Neuropharmacology 1987, 26:1721-1725.
35. Perry T.L., Bratty P.J., Hansen S., Kennedy J., Urquhart N., Dolman C.L. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch. Neurol. 1975, 32:108-113.
36. Saransaari P., Oja S.S. Taurine and neural cell damage. Amino Acids 2000, 19:509-526.
37. Satoh H. Cardiac actions of taurine as a modulator of the ion channels. Adv. Exp. Med. Biol. 1998, 442:121-128.
38. Sawamura A., Sada H., Azuma J., Kishimoto S., Sperelakis N. Taurine modulates ion influx through cardiac Ca2+ channels. Cell Calcium 1990, 11:251-259.
39. Seidel J.C., Nath N., Harper A.E. Diet and cholesterolemia. V. Effects of sulfur-containing amino acids and protein. J. Lipid Res. 1960, 1:474-481.
40. Shin H.K., Linkswiler H.M. Tryptophan and methionine metabolism of adult females as affected by vitamin B-6 deficiency. J. Nutr. 1974, 104:1348-1355.
41. Sykova E., Mazel T., Vargova L., Vorisek I., Prokopova-Kubinova S. Extracellular space diffusion and pathological states. Prog. Brain Res. 2000, 125:155-178.
42. Timbrell J.A., Seabra V., Waterfield C.J. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 1995, 26:453-462.
43. Van Gelder N. Neuronal discharge hypersynchrony and the intracranial water balance in relation to glutamic acid and taurine redistribution: migraine and epilepsy. Taurine: Functional Neurochemistry, Physiology, and Cardiology 1990, vol. 351. Wiley-Liss, New York City, NY.
44. Van Gelder N.M., Sherwin A.L., Sacks C., Anderman F. Biochemical observations following administration of taurine to patients with epilepsy. Brain Res. 1975, 94:297-306.
45. Wade J.V., Olson J.P., Samson F.E., Nelson S.R., Pazdernik T.L. A possible role for taurine in osmoregulation within the brain. J. Neurochem. 1988, 51:740-745.
46. Ward R.J., Francaux M., Cuisinier C., Sturbois X., De Witte P. Changes in plasma taurine levels after different endurance events. Amino Acids 1999, 16:71-77.
47. Waterfield C.J., Turton J.A., Scales M.D., Timbrell J.A. Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats. Arch. Toxicol. 1991, 65:548-555.
48. Wong A.A, Read S.J. Early changes in physiological variables after stroke. Ann. Indian Acad. Neurol. 2008, 11:207-220.